Minimum Inhibitory Concentrations for Ceftiofur and Comparator Antimicrobial Agents against Bacterial Pathogens of Veterinary Importance to Cattle from 1997 to 2001

Authors

  • S. A. Salmon Food Animal Development, Pharmacia Animal Health, Kalamazoo, Michigan 49001
  • E. S. Portis Food Animal Development, Pharmacia Animal Health, Kalamazoo, Michigan 49001
  • C. J. Lindeman Food Animal Development, Pharmacia Animal Health, Kalamazoo, Michigan 49001

DOI:

https://doi.org/10.21423/aabppro20035324

Keywords:

ceftiofur, BRD, bovine respiratory disease, pathogen susceptibility

Abstract

Ceftiofur is an extended spectrum cephalosporin antimicrobial agent that was developed solely for veterinary therapeutic use, and was first approved for the treatment of bovine respiratory disease (BRD) in 1988 by the FDA-CVM. In 1997 Pharmacia Animal Health (PAH) initiated a target pathogen susceptibility monitoring program, and continues to monitor the in vitro activity of ceftiofur as well as other antimicrobials used in the treatment of BRD. This paper discusses the results of monitoring the sensitivity of BRD isolates to ceftiofur over the last four years.

Cover image of the 36th Conference Proceedings: Holstein cows standing in a row at a fence. One cow has put her head through the fence and is curiously inspecting a pile of hay. Yellow background.

Downloads

Published

2003-09-18

Issue

2003

Section

Research Summaries - General